ARTICLE | Deals
Via Mammoth deal, Vertex gains small CRISPR nucleases
CRISPR company pushes further into therapeutics
October 26, 2021 1:03 PM UTC
Vertex is expanding its gene editing capabilities again, this time via a deal with Jennifer Doudna-founded Mammoth that gives it access to some of the smallest CRISPR nucleases identified to date.
The partners teamed up to develop in vivo gene editing therapies for two undisclosed indications based on the next-generation CRISPR gene editing that Mammoth Biosciences is developing. ...
BCIQ Company Profiles
BCIQ Target Profiles